1. Home
  2. PAVS vs TLSA Comparison

PAVS vs TLSA Comparison

Compare PAVS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paranovus Entertainment Technology Ltd.

PAVS

Paranovus Entertainment Technology Ltd.

N/A

Current Price

$4.03

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$1.15

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAVS
TLSA
Founded
2004
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
145.1M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
PAVS
TLSA
Price
$4.03
$1.15
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $7.97
AVG Volume (30 Days)
11.2K
★ 545.0K
Earning Date
08-14-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$541.46
N/A
Revenue Next Year
$1.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.76
52 Week High
$26.69
$2.33

Technical Indicators

Market Signals
Indicator
PAVS
TLSA
Relative Strength Index (RSI) 39.15 59.09
Support Level $3.86 $0.90
Resistance Level $5.55 $1.20
Average True Range (ATR) 0.23 0.09
MACD 0.01 0.02
Stochastic Oscillator 10.00 94.69

Price Performance

Historical Comparison
PAVS
TLSA

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: